The promising results of this study, combined with the established involvement of VCAM-1 in CRC progression, warrant investigations into the therapeutic effects of anti-VCAM-1 antibodies on specific colon cancer lines [51]. The gene discussed is VCAM1; the disease is colorectal carcinoma.